C

Charles River Laboratories International
D

CRL

118.410
USD
1.56
(1.34%)
Market Closed
Volume
50,622
EPS
9
Div Yield
-
P/E
592
Market Cap
5,815,791,458
Related Instruments
NEOUSD
NEOUSD
-0.08928
(-1.54%)
5.70262 USD
ABT
ABT
1.930
(1.47%)
132.820 USD
BDX
BDX
-0.770
(-0.45%)
168.780 USD
B
BIO
-4.000
(-1.66%)
236.340 USD
DGX
DGX
0.630
(0.36%)
178.000 USD
DHR
DHR
2.340
(1.19%)
199.020 USD
ILMN
ILMN
1.395
(1.82%)
77.905 USD
MTD
MTD
44.40
(4.20%)
1,100.79 USD
N
NEO
0.46000
(6.34%)
7.72000 USD
P
PRGO
0.345
(1.36%)
25.630 USD
TMO
TMO
3.67
(0.87%)
423.51 USD
More
News

Title: Charles River Laboratories International

Sector: Healthcare
Industry: Diagnostics & Research
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.